Patent details

Basic Information

Publication number:

EP2558498

PCT Application Number:

PCT/US/2011/032355

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117301184

PCT Publication Number:

WO/2011/130434

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF

French Title of Invention:

ANTICORPS QUI SE LIENT AU CD27 HUMAIN ET UTILISATIONS DE CEUX-CI

German Title of Invention:

HUMANE CD27-BINDENDE ANTIKÖRPER UND IHRE VERWENDUNG

SPC Number:

Dates

Filing date:

13/04/2011

Grant date:

12/10/2016

EP Publication Date:

12/10/2016

PCT Publication Date:

20/10/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/02/2013

EP B1 Publication Date:

12/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/04/2017

Expiration date:

13/04/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/04/2011

 

 

Name:

Celldex Therapeutics Inc.

Address:

119 Fourth Avenue, Needham, MA 02494-2725, United States (US)

Inventor

1

Name:

THOMAS Lawrence, J.

Address:

United States (US)

2

Name:

HE Lizhen

Address:

United States (US)

3

Name:

MARSH Henry, C.

Address:

United States (US)

4

Name:

KELER Tibor

Address:

United States (US)

5

Name:

VITALE Laura, A.

Address:

United States (US)

Priority

1

Priority Number:

323720 P

Priority Date:

13/04/2010

Priority Country:

United States (US)

2

Priority Number:

471459 P

Priority Date:

04/04/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/28;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages